Literature DB >> 17084529

Early dysregulation of cripto-1 and immunomodulatory genes in the cerebral cortex in a macaque model of neuroAIDS.

Edward B Stephens1, Mollie Jackson, Lisa Cui, Eric Pacyniak, Rajani Choudhuri, Christopher S Liverman, David S Salomon, Nancy E J Berman.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) and related primate lentiviruses are known to enter the central nervous system (CNS) during the primary phase of infection. Neuroinvasion by simian immunodeficiency virus and simian human immunodeficiency virus (SHIV) is characterized by transient meningitis and astrocytosis. In this report, we used targeted cytokine cDNA arrays to analyze cortical brain tissue from four pig-tailed macaques inoculated for 2 weeks with pathogenic SHIV(50OLNV) and a normal age-matched pig-tailed macaque. Our results revealed that eight genes were significantly upregulated in all four macaques. These included: leukocyte interferon inducible peptide, corticotrophin releasing factor receptor 1, interleukin 6, CDW40 antigen, cysteine-rich fibroblast growth factor, neurotrophin 3, ciliary neurotrophin factor receptor and cripto-1. The upregulation of three of these genes was confirmed by reverse transcriptase PCR (RT-PCR). Since cripto-1 had not been previously identified within specific cell types within the primate central nervous system, we performed immunohistochemical studies, which revealed the presence of cripto-1 in neurons. RT-PCR studies demonstrated that cripto-1 mRNA was widely expressed in the CNS. These results indicate that immunomodulatory genes are upregulated during the primary phase of infection of the central nervous system. Cripto-1, which acts as a survival factor in tumor cells and may be neuroprotective, is expressed in neurons within the CNS and is upregulated during viral invasion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084529     DOI: 10.1016/j.neulet.2006.07.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  Targeting the embryonic gene Cripto-1 in cancer and beyond.

Authors:  Caterina Bianco; David S Salomon
Journal:  Expert Opin Ther Pat       Date:  2010-11-13       Impact factor: 6.674

Review 2.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Apolipoprotein E-dependent differences in innate immune responses of maturing human neuroepithelial progenitor cells exposed to HIV-1.

Authors:  Rebeca Geffin; Ricardo Martinez; Roberto Perez; Biju Issac; Micheline McCarthy
Journal:  J Neuroimmune Pharmacol       Date:  2013-06-07       Impact factor: 4.147

Review 4.  Nonhuman primate models of NeuroAIDS.

Authors:  Rachel Williams; Sirosh Bokhari; Peter Silverstein; David Pinson; Anil Kumar; Shilpa Buch
Journal:  J Neurovirol       Date:  2008-08       Impact factor: 2.643

Review 5.  Common transcriptional signatures in brain tissue from patients with HIV-associated neurocognitive disorders, Alzheimer's disease, and Multiple Sclerosis.

Authors:  Alejandra Borjabad; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-12       Impact factor: 4.147

Review 6.  Gene expression profiles of HIV-1-infected glia and brain: toward better understanding of the role of astrocytes in HIV-1-associated neurocognitive disorders.

Authors:  Alejandra Borjabad; Andrew I Brooks; David J Volsky
Journal:  J Neuroimmune Pharmacol       Date:  2009-08-21       Impact factor: 7.285

Review 7.  HIV Associated Neurocognitive Disorders.

Authors:  Li Zhou; Nitin K Saksena
Journal:  Infect Dis Rep       Date:  2013-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.